Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Genital Herpesvirus Vaccines
Study findings from V. Martinez et al provide new insights into genital herpesvirus vaccines
March 12th, 2008
Researchers detail in 'Treatment to prevent recurrent genital herpes,' new data in genital herpesvirus. "Genital herpes is the leading cause of genital ulcer disease worldwide and is among the most common sexually transmitted diseases. Recurrent genital herpes is associated with major medical and psychosocial morbidities; therefore, suppressive therapy is required, especially in patients with frequent and/or severe episodes," scientists in France report. "A recent meta-analysis evaluated prophylactic regimens in immunocompetent hosts, and proposed four alternatives with similar efficacies: three twice-daily regimens (i.e. acyclovir 400 mg, valaciclovir 250 mg and...
Source: Vaccine Weekly (2008-03-12)
|
